ComorosTuberculosis profile
Population  2014 <1 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.058 (0.041–0.078) 7.5 (5.3–10)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.46 (0.24–0.76) 60 (31–98)
Incidence  (includes HIV+TB) 0.27 (0.22–0.32) 35 (28–41)
Incidence (HIV+TB only) <0.01 (<0.01–0.01) 1.1 (0.88–1.3)
         
Case detection, all forms (%) 56 (47–68)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 1.7 (0.3–3.1) 17 (4.4–30)
MDR-TB cases among notified pulmonary
TB cases
2 (0–4) 1 (0–2)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 83   4
Pulmonary, clinically diagnosed 29   0
Extrapulmonary 32   0
       
Total new and relapse 148    
Previously treated, excluding relapses 2    
Total cases notified 150    
Among 143 new and relapse cases:
 cases aged under 15 years; male:female ratio: 1.6
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed RR-/MDR-TB cases     0
Patients started on MDR-TB treatment ***     0
TB/HIV 2014 Number (%)
TB patients with known HIV status 1 (<1)
HIV-positive TB patients 1 (100)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 1 (100)
HIV-positive people screened for TB 1  
HIV-positive people provided with IPT 1  
Treatment success rate and cohort size (%) Cohort
New cases registered in 2013 (94) 67
Previously treated cases registered in 2013 (67) 3
HIV-positive TB cases, all types, registered in 2013 (50) 4
RR-/MDR-TB cases started on second-line treatment in 2012   0
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? No
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-07-29 Data: www.who.int/tb/data